Within in situ specimens, CD68 was used as a marker for microglia/macrophages (Figure 3A) in combination with luxol fast blue (LFB) staining for myelin (Figure 3B) to identify a mixed active/inactive MS lesion via bright-field microscopy, as previously described in our lab [22]. The gene discussed is CD68; the disease is myeloid sarcoma.